100,000 poop samples could unlock secrets of gut health and disease

NCT ID NCT05758961

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to collect 100,000 fecal samples from adults living in France to better understand the gut microbiome—the community of bacteria in our intestines. Researchers will analyze how diet, lifestyle, age, and health conditions like diabetes, obesity, and Parkinson's disease relate to differences in gut bacteria. The goal is to create a detailed map of gut microbiome diversity, which could help scientists develop future treatments or prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could reveal how gut bacteria vary with diet and disease, potentially guiding future treatments for conditions like diabetes, obesity, and Parkinson's.
What could go wrong
This is an observational study, not a treatment trial. It may not directly lead to cures, and findings might not apply to people outside France.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 100,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2022

Expected to finish

Sep 2042

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

General population residing in France

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Persons over the age of 18 living in France. * Consent form signed electronically. Non inclusion Criteria: * Non-adult person (declarative); * Person not living in France (declarative); * Persons subject to a protective measure, in particular under guardianship or curatorship or unable to express their consent (declarative); * Person having had a colectomy (declarative); * Person with a digestive stoma (declarative); * Person who has not signed the consent; * Person who did not answer the entry questionnaire; * Person who has not sent a compliant stool sample; * Antibiotic intake in the 3 months before inclusion (declarative); * Performing a colonoscopy in the 3 months preceding inclusion (declarative).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for General population are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Centre de Recherche sur Volontaire

    RECRUITING

    Bobigny, 93000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.